A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion
Phase of Trial: Phase III
Latest Information Update: 05 Aug 2018
Price : $35 *
At a glance
- Drugs Alteplase (Primary) ; Aspirin
- Indications Retinal vascular occlusion
- Focus Therapeutic Use
- Acronyms THEIA
- 12 Jun 2018 Planned End Date changed from 1 Jan 2020 to 1 Sep 2020.
- 12 Jun 2018 Planned primary completion date changed from 1 Jan 2020 to 1 Jun 2020.
- 12 Jun 2018 Status changed from not yet recruiting to recruiting.